B
Catalyst Pharmaceuticals, Inc. CPRX
$21.02 $0.150.72%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

12/31/2024 09/30/2024 06/30/2024 03/31/2024 12/31/2023
Revenue 23.49% 32.17% 43.42% 60.38% 85.90%
Total Other Revenue -- -- -- -- --
Total Revenue 23.49% 32.17% 43.42% 60.38% 85.90%
Cost of Revenue 32.14% -112.51% -8.50% -5.75% -1.35%
Gross Profit 22.15% 132.45% 56.98% 79.88% 115.44%
SG&A Expenses 32.93% 66.02% 90.17% 114.47% 134.23%
Depreciation & Amortization 14.78% 54.00% 124.82% 363.73% 2,865.85%
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -4.75% 5.15% 111.61% 144.15% 177.13%
Operating Income 124.77% 129.15% -37.87% -34.77% -14.75%
Income Before Tax 128.82% 133.62% -35.40% -30.73% -9.75%
Income Tax Expenses 126.72% 144.96% -13.24% -15.88% 6.75%
Earnings from Continuing Operations 129.50% 130.18% -41.02% -34.49% -14.05%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 129.50% 130.18% -41.02% -34.49% -14.05%
EBIT 124.77% 129.15% -37.87% -34.77% -14.75%
EBITDA 94.58% 110.85% -20.77% -10.83% 16.12%
EPS Basic 104.98% 110.06% -47.03% -37.90% -16.13%
Normalized Basic EPS 105.14% 108.04% -42.50% -36.98% -15.38%
EPS Diluted 114.48% 122.52% -47.07% -39.35% -18.70%
Normalized Diluted EPS 114.66% 119.62% -42.97% -38.15% -17.58%
Average Basic Shares Outstanding 11.46% 8.90% 6.80% 4.83% 2.81%
Average Diluted Shares Outstanding 11.55% 8.81% 3.36% 1.92% 0.94%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings